Scientists have discovered that the drug losartan, commonly prescribed for high blood pressure, boosts brown adipose tissue activity in mice, enhancing their metabolism. This indicates that repurposing losartan—an angiotensin receptor blocker (ARB) with a well-known safety profile—may be a clinically viable method of stimulating brown fat, which has been linked to improved cardiovascular health and, reported for the first time in this study, psychiatric health.
Losartan Drug Shows Potential to Enhance Metabolism by Stimulating Brown Fat Activity
Scientists have found that losartan, a drug used for high blood pressure, increases brown fat activity in mice, which may improve metabolism and health. This research could lead to new treatments that benefit cardiovascular and psychiatric health. For Iran, this could impact healthcare strategies and drug repurposing efforts.
👥 Key Players
📰 What Happened
Researchers have found that losartan, a drug used for high blood pressure, can enhance metabolism by increasing brown fat activity in mice. This discovery suggests potential new uses for losartan in improving cardiovascular and psychiatric health.
- Losartan is an angiotensin receptor blocker (ARB) with a well-known safety profile.
- The study indicates a link between brown fat activity and improved health outcomes.
💡 Why It Matters
📚 Background
Brown adipose tissue is known to play a role in metabolism and energy expenditure, making it a target for obesity and metabolic disorder treatments. Losartan is primarily used for hypertension but may have broader applications.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%